Danaher Co. (NYSE:DHR) Shares Sold by Investidor Profissional Gestao de Recursos Ltda.

Investidor Profissional Gestao de Recursos Ltda. cut its holdings in Danaher Co. (NYSE:DHR) by 29.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,814 shares of the conglomerate’s stock after selling 1,199 shares during the quarter. Danaher makes up approximately 0.4% of Investidor Profissional Gestao de Recursos Ltda.’s portfolio, making the stock its 16th largest holding. Investidor Profissional Gestao de Recursos Ltda.’s holdings in Danaher were worth $782,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Rockport Wealth LLC purchased a new position in shares of Danaher during the 1st quarter worth about $516,000. O Shaughnessy Asset Management LLC raised its stake in Danaher by 26.0% during the first quarter. O Shaughnessy Asset Management LLC now owns 43,730 shares of the conglomerate’s stock worth $10,920,000 after purchasing an additional 9,031 shares during the period. PYA Waltman Capital LLC boosted its holdings in shares of Danaher by 10.0% in the 1st quarter. PYA Waltman Capital LLC now owns 32,429 shares of the conglomerate’s stock valued at $8,098,000 after purchasing an additional 2,935 shares during the last quarter. Lake Street Advisors Group LLC grew its stake in shares of Danaher by 50.3% during the 1st quarter. Lake Street Advisors Group LLC now owns 6,211 shares of the conglomerate’s stock valued at $1,553,000 after buying an additional 2,079 shares during the period. Finally, Puzo Michael J increased its holdings in shares of Danaher by 9.0% during the 1st quarter. Puzo Michael J now owns 45,993 shares of the conglomerate’s stock worth $11,485,000 after buying an additional 3,788 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Performance

Shares of NYSE DHR opened at $230.50 on Monday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm’s 50-day moving average price is $262.20 and its two-hundred day moving average price is $260.57. Danaher Co. has a 52-week low of $206.30 and a 52-week high of $281.70. The stock has a market capitalization of $166.48 billion, a P/E ratio of 43.99, a P/E/G ratio of 4.24 and a beta of 0.85.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 EPS. The business’s revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. KeyCorp boosted their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. The Goldman Sachs Group lifted their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Wells Fargo & Company began coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective for the company. Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Finally, Bank of America upped their price target on shares of Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.